(Q33346256)

26 July 2017

Lepirudin use in a neonate with heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

Thuy N Nguyen

1

1 reference

26 July 2017

Peter Gal

series ordinal

2

1 reference

26 July 2017

J Laurence Ransom

series ordinal

3

1 reference

26 July 2017

Rita Carlos

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Annals of Pharmacotherapy

26 July 2017

1 reference

26 July 2017

37

1 reference

26 July 2017

2

1 reference

26 July 2017

229-233

1 reference

Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium

26 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Lepirudin anticoagulation for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Heparin-induced thrombocytopenia in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Recombinant hirudin in clinical practice: focus on lepirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002800303700214

10.1177/106002800303700214

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference